Cargando…

Circulating Ism1 Reduces the Risk of Type 2 Diabetes but not Diabetes-Associated NAFLD

PURPOSE: To examine the association of serum Ism1, a new adipokine that can regulate glucose uptake, with type 2 diabetes (T2D) in a Chinese population. Considering high prevalence of Nonalcoholic Fatty Liver Disease in patients with type 2 diabetes and the regulating role of Ism1 on glucose uptake...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jiajia, Du, Juan, Ge, Xiaoxu, Peng, Wenfang, Guo, Xirong, Li, Wenyi, Huang, Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195582/ https://www.ncbi.nlm.nih.gov/pubmed/35712241 http://dx.doi.org/10.3389/fendo.2022.890332

Ejemplares similares

Metabolic remodeling of glycerophospholipids acts as a signature of dulaglutide and liraglutide treatment in recent-onset type 2 diabetes mellitus
por: Du, Juan, et al.
Publicado: (2023)

The analysis of risk factors for diabetic kidney disease progression: a single-centre and cross-sectional experiment in Shanghai
por: Liu, Wen, et al.
Publicado: (2022)

Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2021)

Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes
por: Abu-Farha, Mohamed, et al.
Publicado: (2022)

Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2022)

Metabolic alteration of circulating steroid hormones in women with gestational diabetes mellitus and the related risk factors
por: Yang, Na, et al.
Publicado: (2023)

Profile Screening of Differentially Expressed lncRNAs of Circulating Leukocytes in Type 2 Diabetes Patients and Differences From Type 1 Diabetes
por: Lv, Jianyi, et al.
Publicado: (2022)

Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
por: Cuthbertson, Daniel J., et al.
Publicado: (2021)

Risk of infections in patients with NAFLD and Type 2 Diabetes under treatment with SGLT2 inhibitors and relationship with liver outcomes: A retrospective case-control study
por: Bañares, Juan, et al.
Publicado: (2022)

Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023)

OR21-1 Adiposity and Diabetes Genetic Risk Modulates Causal Effects of BMI and Type 2 Diabetes on NAFLD: A Wax-and-Wane Pattern
por: Wang, Ningjian, et al.
Publicado: (2019)

THU586 Lipid Species In Non-alcoholic Fatty Liver Disease (NAFLD) In Type 1 Diabetes
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

Depiction of immune heterogeneity of peripheral blood from patients with type II diabetic nephropathy based on mass cytometry
por: Jin, Juan, et al.
Publicado: (2023)

The Relationship Between Circulating Growth Differentiation Factor 15 Levels and Diabetic Retinopathy in Patients With Type 2 Diabetes
por: Niu, Yixin, et al.
Publicado: (2021)

Corrigendum: Depiction of immune heterogeneity of peripheral blood from patients with type II diabetic nephropathy based on mass cytometry
por: Jin, Juan, et al.
Publicado: (2023)

Correlation between long-term use of metformin and incidence of NAFLD among patients with type 2 diabetes mellitus: A real-world cohort study
por: Huang, Kuang-Hua, et al.
Publicado: (2022)

Circulating biomarkers during progression to type 1 diabetes: A systematic review
por: Brenu, Ekua W., et al.
Publicado: (2023)

HNF1A：From Monogenic Diabetes to Type 2 Diabetes and Gestational Diabetes Mellitus
por: Li, Li-Mei, et al.
Publicado: (2022)

THU585 Non-alcoholic Fatty Liver Disease (NAFLD), A Silent But Emerging Problem In Type 1 Diabetes
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

Nomogram Prediction for the Risk of Diabetic Foot in Patients With Type 2 Diabetes Mellitus
por: Wang, Jie, et al.
Publicado: (2022)

Increased Circulating Levels of Ectodysplasin A in Newly Diagnosed Type 2 Diabetic Patients
por: Deng, Xia, et al.
Publicado: (2021)

Footprint of pancreas infiltrating and circulating immune cells throughout type 1 diabetes development
por: Bruggeman, Ylke, et al.
Publicado: (2023)

Causal relationship between circulating immune cells and the risk of type 2 diabetes: a Mendelian randomization study
por: Li, Jin, et al.
Publicado: (2023)

Editorial: The NAFLD-MAFLD conundrum
por: Dalbeni, Andrea, et al.
Publicado: (2023)

Human Genetics to Identify Therapeutic Targets for NAFLD: Challenges and Opportunities
por: Du, Xiaomi, et al.
Publicado: (2021)

Increased Circulation and Adipose Tissue Levels of DNAJC27/RBJ in Obesity and Type 2-Diabetes
por: Cherian, Preethi T., et al.
Publicado: (2018)

Gut-Based Strategies to Reduce Postprandial Glycaemia in Type 2 Diabetes
por: Kamruzzaman, Md, et al.
Publicado: (2021)

Resveratrol Reduces Glucolipid Metabolic Dysfunction and Learning and Memory Impairment in a NAFLD Rat Model: Involvement in Regulating the Imbalance of Nesfatin-1 Abundance and Copine 6 Expression
por: Chen, Xing-Xing, et al.
Publicado: (2019)

A Qualitative Exploration of Self-Management Behaviors and Influencing Factors in Patients With Type 2 Diabetes
por: Peng, Xi, et al.
Publicado: (2022)

Development of predictive nomograms clinical use to quantify the risk of diabetic foot in patients with type 2 diabetes mellitus
por: Peng, Bocheng, et al.
Publicado: (2023)

Cardiac Autonomic Dysfunction Is Associated With Risk of Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus
por: Zeng, Haixia, et al.
Publicado: (2022)

FGF21 Serum Levels in the Early Second Trimester Are Positively Correlated With the Risk of Subsequent Gestational Diabetes Mellitus: A Propensity-Matched Nested Case-Control Study
por: Wang, Zhiheng, et al.
Publicado: (2021)

Clinical Characteristics and Risk of Diabetic Complications in Data-Driven Clusters Among Type 2 Diabetes
por: Xing, Lin, et al.
Publicado: (2021)

Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients’ Age and Disease Duration
por: Arcangeli, Adolfo, et al.
Publicado: (2017)

Higher Levels of ANGPTL5 in the Circulation of Subjects With Obesity and Type 2 Diabetes Are Associated With Insulin Resistance
por: Alghanim, Ghazi, et al.
Publicado: (2019)

Circulating metabolic signatures of rapid and slow progression to type 1 diabetes in islet autoantibody-positive children
por: Lamichhane, Santosh, et al.
Publicado: (2023)

Risk factors and drug discovery for cognitive impairment in type 2 diabetes mellitus using artificial intelligence interpretation and graph neural networks
por: Zhang, Xin, et al.
Publicado: (2023)

Predictors of Cognitive Decline in Older Adult Type 2 Diabetes from the Veterans Affairs Diabetes Trial
por: Zimering, Mark B., et al.
Publicado: (2016)

Circulating Irisin Is Reduced in Male Patients with Type 1 and Type 2 Myotonic Dystrophies
por: Dozio, Elena, et al.
Publicado: (2017)

Black Looks ... at 'Isms'
por: Black, Douglas
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_d6tjh02sg86v5eark7kthkfjf0